MANI TROCAR KIT 23G S - Product Usage: for use in injecting perfusate or aspirating out intraocul...

FDA Device Recall #Z-0557-2021 — Class II — October 27, 2020

Recall Summary

Recall Number Z-0557-2021
Classification Class II — Moderate risk
Date Initiated October 27, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mani, Inc. - Kiyohara Facility
Location Utsunomiya, N/A
Product Type Devices
Quantity 6 units (US)

Product Description

MANI TROCAR KIT 23G S - Product Usage: for use in injecting perfusate or aspirating out intraocular materials during ophthalmic surgery, Ref: MTK 23S

Reason for Recall

Dimensions of the Luer connector parts out of specification, may cause leakage of fluid and unintended disconnection during use

Distribution Pattern

US Nationwide distribution in the state of MO.

Lot / Code Information

Lot Codes: V180077300, Exp Date: 2020/10 and V200009500, EXp Date: 2022/03

Other Recalls from Mani, Inc. - Kiyohara Facility

Recall # Classification Product Date
Z-1468-2023 Class II Mani Trocar Kit, Model MTK23S and Model MTK25S ... Feb 20, 2023
Z-0558-2021 Class II MANI Infusion Cannula 23G S - Product Usage: fo... Oct 27, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.